Cancer is currently ineffectively treated using therapeutic drugs, and is also able to resist
drug action, resulting in increased side effects following drug treatment. A novel therapeutic …

In recent years, the number of people suffering from cancer and multi-resistant infections has
increased, such that both diseases are already seen as current and future major causes of …

Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many
organisms. Although AMPs have been essentially studied and developed as potential …

Cancer remains a major killer worldwide. Traditional methods of cancer treatment are
expensive and have some deleterious side effects on normal cells. Fortunately, the …

Abstract Antimicrobial Peptides (AMPs) have been considered as potential alternatives for
infection therapeutics since antibiotic resistance has been raised as a global problem. The …

Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …

Use of therapeutic peptides in cancer therapy has been receiving considerable attention in
the recent years. Present study describes the development of computational models for …

In this study, two peptides isolated from the protein hydrolysate of blood clam (Tegillarca
granosa) muscle were identified as Trp-Pro-Pro (BCP-A) and Gln-Pro (BCP-B), with …

Peptide therapy has started since 1920s with the advent of insulin application, and now it
has emerged as a new approach in treatment of diseases including cancer. Using anti …

Anticancer peptides (ACPs) have emerged as a new class of therapeutic agent for cancer
treatment due to their lower toxicity as well as greater efficacy, selectivity and specificity …